Objective : The aim of this study is to evaluate the clinical course of intracranial aneurysm in patients aged 65 years and older and the immediate outcome after its aggressive management.
INTRODUCTION
The definition of 'elderly' may vary according to chronological, biological, psychological, and social aspects, however, most developed countries have ac- 
MATERIALS AND METHODS
This is a retrospective, cross-sectional study from a Analysis for other variables including age, co-existence of other medical diseases such as hypertension and diabetes mellitus, and medications taken such as antiplatelet or anticoagulants was performed using the same method. As shown in Table 2 , high grade HHG, advanced age, and IVH were strong predictors of poor outcome. Table 5 
RESULTS

Patients and characteristics
DISCUSSION
In this study, the primary finding was that patients with high grade HHG, increasing age, and intraventricular hematoma (IVH, FG4) had poor clinical outcomes as compared to patients without these factors, which were as follows. The initial clinical presentation of patients is the highest predictive power of the outcome. In our series, the final mortality rate and percentage of severely disabled patients with high grade HHG (HHG IV, V) was 28.3% and 24.5%, respectively. A favorable outcome was achieved in 31% of treated patients, higher than the result from previously published studies. Our study supports the idea that surgical treatment of UIAs in the elderly should be advocated in making decisions on the optimal treatment strategy after careful assessment of each individual's circumstances.
In the ruptured aneurysm group, nine (47.4%) patients died from 'other' causes unrelated to SAH.
Among the eight patients who died, five died of pneumonia and three died of sepsis and/or multiorgan failure. According to these results, more than one-third of the patients died within the acute period of the SAH, even if it was not due to the hemorrhage.
Clinical care of elderly patients is challenging because of a greater chance of pharmacological complications, cardiopulmonary dysfunction, and so on. Elderly patients who survive SAH often face prolonged management in an intensive care unit (ICU), including treatment for multiple potential neurological and medical complications. 13)18) Therefore, for proper co-management of these patients, in order to handle multiple issues, it is necessary to employ a more specialized neurointensivist dedicated to the ICU. 9) This study is limited by the fact that it was a retrospective review, with a limited number of patients at a single institution and no strictly defined selection criteria for the treatment procedure along with a lack of long-term follow up results. Lack of standard treatment guidelines and sufficient prognostic domestic data concerning treatment of aneurysms in the elderly make it difficult for clinicians when it comes to deciding on the proper treatment modality in such patients.
We believe that our study may provide a valuable guide to help in decision making regarding treatment enrollment of elderly patients who could benefit from treatment, despite the known challenges in the management of this age group.
CONCLUSION
According to our data, elderly patients with high grade HHG and IVH are truly associated with poor outcome, so that the indication for aggressive therapy should be considered carefully. To improve outcomes in elderly SAH patients, co-management by specialized neurointensivists who can handle patients with multiple conditions should be considered. According to our data, all elderly patients with UIAs had an excellent outcome, regardless of the treatment modality.
Treatment of unruptured intracranial aneurysms can be considered in an optimistic way.
